High-performance immune diagnosis of tuberculosis: Use of phage display and synthetic peptide in an optimized experimental design

Serena, Natália Notto; Boschero, Raphael Aparecido; Santiani, Manuel Hospinal; Pacce, Violetta Dias; Vedova-Costa, Jean Michel Dela; Magalhães, None Francisco Beraldi De; Wiedmar, Carlos; Alban, Silvana Maria; Soccol, Carlos Ricardo; Soccol, Vanete Thomaz

doi:10.1016/j.jim.2022.113242

Cited by 3 publications

(2 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There are other ways to increase the effi ciency of serological tests to determine anti-TB antibodies today. For example, increasing the number of antigens used in the test (before Jacobs R, et al (2022) [14]) in combination with the defi nition of infl ammatory markers, search and the use of several MBT mimotopes to determine the corresponding IgG in the blood of patients [12].…”

Section: Antibiotic Resistance Typesmentioning

confidence: 99%

“…In particular, it is promising to determine circulating microRNAs (miRNAs) as a potential biomarker to detect tuberculosis [9], immunoassays for measuring the reduced CD27 expression in T-cells in blood [10], and determining complex metabolites in the blood using nuclear-magnetic resonance method [11]. Brazilian scientists used new MBT peptide mimotopes for serodiagnosis of TB (IgG antibodies) and achieved 100% sensitivity and specifi city when tested on a 100-sera panel [12]. This is a practical and cost-eff ective approach suitable for large-scale TB screening.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Detection of Specific Antibodies Using Mpt83-Mpt63 Fusion Protein in Patients With Destructive Pulmonary Tuberculosis

Rekalova

Panasiukova²,

Pohrebna³

et al. 2022

PSSS MS

View full text Add to dashboard Cite

Introduction. The development of eff ective test systems for tuberculosis (TB) diagnosis and the study of factors infl uencing their sensitivity and specifi city constitute urgent tasks given the unstable epidemiological situation with TB in Ukraine and the world. The study aimed to determine the clinical and laboratory features of pulmonary TB that may aff ect the sensitivity of IgG TB antibody detection in human serum by the immuno-enzyme test system "IB-Chem Anti-Mycobacterium tuberculosis", which was developed at the Palladin Institute of Biochemistry of the NAS of Ukraine and uses recombinant fusion protein MPT83-MPT63 as an antigen. Methods. Sera of 62 patients with chemoresistant pulmonary TB were tested for TB antibodies using an indirect enzyme-linked immunosorbent assay. Dependence of the obtained results on clinical symptoms and signs of pulmonary TB, the frequency of diff erent types of antibiotic resistance, cellular and biochemical parameters of blood were analysed. Results. The sensitivity of the immuno-enzyme test system "IB-Chem Anti-Mycobacterium tuberculosis" for detecting human IgG TB antibodies using recombinant fusion protein MPT83-MPT63 was found to constitute 71.0%; it reached 81.3% in patients with destructive pulmonary TB. Conclusion. The developed test system should primarily be used for the TB diagnosis in patients with destructive changes in the lungs where the diagnostic effi ciency of this test system reaches high indicators.

show abstract

Section: Antibiotic Resistance Typesmentioning

confidence: 99%

mentioning

confidence: 99%

Detection of Specific Antibodies Using Mpt83-Mpt63 Fusion Protein in Patients With Destructive Pulmonary Tuberculosis

Rekalova

Panasiukova²,

Pohrebna³

et al. 2022

PSSS MS

View full text Add to dashboard Cite

show abstract

The use of peptides for immunodiagnosis of human Chagas disease

Ribeiro,

Silva,

Lopes

et al. 2024

Amino Acids

View full text Add to dashboard Cite

Chagas disease, caused by the protozoa Trypanosoma cruzi, continues to be a serious public health problem in Latin America, worsened by the limitations in its detection. Given the importance of developing new diagnostic methods for this disease, the present review aimed to verify the number of publications dedicated to research on peptides that demonstrate their usefulness in serodiagnosis. To this end, a bibliographic survey was conducted on the PubMed platform using the keyword “peptide” or “epitope” combined with “Chagas disease” or “Trypanosoma cruzi”; “diagno*” or “serodiagnosis” or “immunodiagnosis”, without period restriction. An increasing number of publications on studies employing peptides in ELISA and rapid tests assays was verified, which confirms the expansion of research in this field. It is possible to observe that many of the peptides tested so far originate from proteins widely used in the diagnosis of Chagas, and many of them are part of commercial tests developed. In this sense, as expected, promising results were obtained for several peptides when tested in ELISA, as many of them exhibited sensitivity and specificity values above 90%. Furthermore, some peptides have been tested in several studies, confirming their diagnostic potential. Despite the promising results observed, it is possible to emphasize the need for extensive testing of peptides, using different serological panels, in order to confirm their potential. The importance of producing an effective assay capable of detecting the clinical stages of the disease, as well as new immunogenic antigens that enable new serological diagnostic tools for Chagas disease, is evident.

show abstract

New advances in the treatments of drug-resistant tuberculosis

Mahmoud

Tan

2023

Expert Review of Anti-infective Therapy

View full text Add to dashboard Cite

High-performance immune diagnosis of tuberculosis: Use of phage display and synthetic peptide in an optimized experimental design

Cited by 3 publications

References 38 publications

Detection of Specific Antibodies Using Mpt83-Mpt63 Fusion Protein in Patients With Destructive Pulmonary Tuberculosis

Detection of Specific Antibodies Using Mpt83-Mpt63 Fusion Protein in Patients With Destructive Pulmonary Tuberculosis

The use of peptides for immunodiagnosis of human Chagas disease

New advances in the treatments of drug-resistant tuberculosis

Contact Info

Product

Resources

About